ViiV Healthcare Gains FDA Approval of Cabenuva as long-Acting Regimen for HIV Treatment
US FDA Approves Cabenuva as Long-Acting Regimen for the Treatment of HIV
ViiV Healthcare wins FDA approval for HIV treatment Cabenuva
Incyte granted FDA priority review for retifanlimab BLA for SCAC
European Commission Authorises the First Complete Long-Acting Injectable HIV Treatment in Europe
Australian government stops development of local COVID-19 vaccine due to false HIV positives